PA
SRAD icon

PharVision Advisers’s Sportradar SRAD Stock Holding History

PharVision Advisers’s Portfolio SRAD Stock Details SRAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,900
Closed -$212K – 573
2025
Q4 		$212K Buy
+8,900
New +$214K 0.11% 514

Other funds holding SRAD

Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
TCMI
Technology Crossover Management IX Menlo Park, California $690M AUM 42.34% 1-Year Est. Return
RM
Radcliff Management New York $197M AUM 46.69% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
SHIM
Spruce House Investment Management New York $3.4B AUM 30.65% 1-Year Est. Return

PharVision Advisers's SRAD Position: Q1 2026 in Review

PharVision Advisers sold out of Sportradar (SRAD) in Q1 2026, closing a stake of 8,900 shares — an estimated $212K sold.

PharVision Advisers first reported a position in SRAD in Q4 2025 and held it in 1 quarter. The position peaked at $212K in Q4 2025. 164 funds tracked by Wall St. Rank hold SRAD as of Q1 2026.

  • PharVision Advisers reported no remaining Sportradar position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 8,900 Sportradar shares in Q1 2026, an estimated $212K.
  • PharVision Advisers first reported a position in Sportradar in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Sportradar position peaked at $212K in Q4 2025.
  • 164 funds tracked by Wall St. Rank held Sportradar as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.